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A Note From NIDA’s Director
N
IDA’s initiative to blend drug abuse science
and practice brings drug abuse researchers
and service providers together in the pages of
this journal and also face-to-face in frequent meetings
and conferences. This past June, more than 600 profes-
sionals from all corners of the addiction field convened
in Miami Beach for “Smart Practice, Practical Science:
Blending Treatment and Research”—2 days of plenary
sessions, breakout panels, and informal collegial discus-
sions. 
Among the educational offerings at the Miami Beach
conference, participants could choose a daylong hands-
on training session in the use of a brand new, research-
proven and community clinic-tested product just released
by still another arm of NIDA’s Blending Initiative. Since
2001, Blending Teams cosponsored by NIDA and the
Substance Abuse and Mental Health Services Administra-
tion, in partnership with the Addiction Technology Transfer
Center, have been working to facilitate the movement of
research findings into mainstream addiction treatment.
Their newest product teaches counselors to maximize
their return on the time they invest in administering the
Addiction Severity Index (ASI). Users learn to integrate
the ASI into the treatment planning and documenting
processes (www.mattc.org/information/smart2).
Meanwhile, in NIDA’s Clinical Trials Network (CTN),
researchers and service providers are jointly designing
and conducting studies to produce community-clinic-
ready solutions to questions of primary clinical impor-
tance. Nearing completion are a comparison of several
treatments for women with co-occurring trauma and sub-
stance abuse disorders, and two studies aimed at curb-
ing the spread of HIV and sexually transmitted diseases
among men and women in drug abuse treatment.
The successful partnerships and exchanges of the
Blending Initiative, now producing results in the Nation’s
treatment facilities, show how powerful the combination
of research and practice can be.
Nora D. Volkow, M.D.
Director
National Institute on Drug Abuse
Kathleen T. Brady, M.D., Ph.D.
Professor, Department of Psychiatry
Medical University of South Carolina
Charleston, South Carolina
Linda Chang, M.D.
Professor, Department of Medicine 
John A. Burns School of Medicine 
University of Hawaii
Honolulu, Hawaii 
James Cornish, M.D.
Director, Pharmacotherapy Division
Center for the Studies of Addiction
University of Pennsylvania and VA Medical Center
Philadelphia, Pennsylvania
Christiane Farentinos, M.D., C.A.D.C. II
Research and Clinical Director
ChangePoint, Inc. 
Portland, Oregon
Joseph Frascella, Ph.D.
Director, Division of Clinical Neuroscience, Development 
and Behavioral Treatment
National Institute on Drug Abuse
Rockville, Maryland
Thomas R. Kosten, M.D.
Professor of Psychiatry
Yale University
Deputy Chief of Psychiatry Research
VA Connecticut Healthcare System
West Haven, Connecticut 
Beverly Pringle, Ph.D. 
Chief, Services Research Branch 
Division of Epidemiology, Services, and Prevention Research 
National Institute on Drug Abuse 
Rockville, Maryland 
Richard A. Rawson, Ph.D.
Associate Director, Integrated Substance Abuse Programs
University of California, Los Angeles, School of Medicine
Los Angeles, California 
Daniel Santisteban, Ph.D.
Associate Professor, Department of Psychiatry and Behavioral Sciences
University of Miami, Miller School of Medicine
Miami, Florida 
James Sorensen, Ph.D.
Professor of Psychiatry
University of California, San Francisco 
San Francisco General Hospital Medical Center
San Francisco, California
SCIENCE & PRACTICE PERSPECTIVES EDITORIAL BOARD